Abivax is a clinical-stage biopharmaceutical company based in Paris, France. It focuses on developing oral therapies that modulate the immune system to treat chronic inflammatory diseases. Its main drug candidate is being studied for inflammatory bowel disease, including ulcerative colitis, and the company also has earlier-stage work in antiviral medicines. Its customers are ultimately patients and healthcare providers, while its development work is carried out with clinical investigators and partners in the medical field.
On this site Abivax SA appears as a stock on the Euronext Paris (France), code ABVX, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #431 of 625 on the Euronext Paris · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for France yet.
TrendWeak
28/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-22.0%
From 52-week high-42.3%
MomentumWeak
40/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-32.5%
6-month return-20.4%
12-month, skipping last month19.6%
Risk (lower is better)Weak
21/100
Volatile, with deep drawdowns.
See the numbers →
Volatility (1 year)88.4%
Worst drawdown (1 year)-48.4%
LiquidityStrong
91/100
Trades actively.
See the numbers →
Avg daily value traded12.76M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for France when fundamentals data for this market is added. All France stocks.
52-wk range 60.45 – 139.00Daily closes, split-adjusted
Signals
50-day average92.35
200-day average99.98
Golden/death cross (60d)Death, 16 days ago
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)4.14
Technical summary
Daily
Strongly bearish
1 bullish · 3 neutral · 12 bearish
Weekly
Bearish
3 bullish · 1 neutral · 8 bearish
Monthly
Neutral
3 bullish · 1 neutral · 4 bearish
Moving averages (daily)
SMA 10
78.84
Bearish
EMA 10
79.72
Bearish
SMA 20
81.30
Bearish
EMA 20
82.48
Bearish
SMA 50
92.35
Bearish
EMA 50
90.02
Bearish
SMA 100
97.82
Bearish
EMA 100
95.04
Bearish
SMA 200
99.98
Bearish
EMA 200
93.27
Bearish
Oscillators (daily)
RSI (14)
36.85
Neutral
MACD (12, 26)
-4.11
Bearish
Momentum (12)
-7.37
Bearish
Stochastic %K (14)
40.29
Neutral
Williams %R (14)
-59.71
Neutral
CCI (20)
-126.3
Bullish
Pivot points (classic, last session)
S3
63.93
S2
67.52
S1
72.73
Pivot
76.32
R1
81.53
R2
85.12
R3
90.33
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.